Actively Recruiting
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Led by Ascendis Pharma Endocrinology Division A/S · Updated on 2026-02-04
500
Participants Needed
27
Research Sites
519 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to further characterise the potential long-term safety risks of lonapegsomatropin in patients treated with lonapegsomatropin under real-world conditions in the post-marketing setting.
CONDITIONS
Official Title
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pediatric patients with growth hormone deficiency (GHD) treated with lonapegsomatropin
- Patients clinically managed in Europe or the USA
- Appropriate written informed consent or assent obtained based on patient age
- Patients willing to comply with study follow-up requirements
You will not qualify if you...
- Participation in any interventional clinical trial for short stature
- Treatment with growth hormone (GH) or IGF-1 therapy other than lonapegsomatropin at enrollment
- Contraindication to lonapegsomatropin treatment
- Closed growth plates (epiphyses)
- Presence of active malignant tumors
- Antitumor therapy within 12 months before starting GH therapy
- Hypersensitivity to somatropin or any excipients in lonapegsomatropin
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 27 locations
1
Ascendis Investigational Site
Phoenix, Arizona, United States, 85054
Actively Recruiting
2
Ascendis Investigational Site
Orange, California, United States, 92868
Actively Recruiting
3
Ascendis Investigational Site
Sacramento, California, United States, 95821
Actively Recruiting
4
Ascendis Investigational Site
San Francisco, California, United States, 94143
Actively Recruiting
5
Ascendis Pharma Investigational Site
Centennial, Colorado, United States, 80112
Actively Recruiting
6
Ascendis Investigational Site
Washington D.C., District of Columbia, United States, 20010
Actively Recruiting
7
Ascendis Investigational Site
Orlando, Florida, United States, 32806
Actively Recruiting
8
Ascendis Investigational Site
Orlando, Florida, United States, 32827
Actively Recruiting
9
Ascendis Investigational Site
Tampa, Florida, United States, 33612
Actively Recruiting
10
Ascendis Investigational Site
Sandy Springs, Georgia, United States, 30350
Actively Recruiting
11
Ascendis Investigational Site
Boise, Idaho, United States, 83712
Actively Recruiting
12
Ascendis Investigational Site
Indianapolis, Indiana, United States, 46202
Actively Recruiting
13
Ascendis Investigational Site
Iowa City, Iowa, United States, 52242
Actively Recruiting
14
Ascendis Investigational Site
Louisville, Kentucky, United States, 40202
Actively Recruiting
15
Ascendis Investigational Site
Minneapolis, Minnesota, United States, 55455
Actively Recruiting
16
Ascendis Investigational Site
Las Vegas, Nevada, United States, 89113
Actively Recruiting
17
Ascendis Investigational Site
Lebanon, New Hampshire, United States, 03756
Actively Recruiting
18
Ascendis Investigational Site
Manchester, New Hampshire, United States, 03104
Actively Recruiting
19
Ascendis Investigational Site
Morristown, New Jersey, United States, 07960
Actively Recruiting
20
Ascendis Investigational Site
New Hyde Park, New York, United States, 11042
Actively Recruiting
21
Ascendis Investigational Site
Cincinnati, Ohio, United States, 45229
Actively Recruiting
22
Ascendis Investigational Site
Portland, Oregon, United States, 97239
Actively Recruiting
23
Ascendis Investigational Site
Columbia, South Carolina, United States, 29203
Actively Recruiting
24
Ascendis Investigational Site
Dallas, Texas, United States, 75390
Actively Recruiting
25
Ascendis Investigational Site
El Paso, Texas, United States, 79907
Actively Recruiting
26
Ascendis Investigational Site
Norfolk, Virginia, United States, 23507
Actively Recruiting
27
Ascendis Investigational Site
Seattle, Washington, United States, 98105
Actively Recruiting
Research Team
D
Deborah Bowlby
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here